TG Therapeutics | TGTX - 流动资产



金融业
股票价格
USD
资产
USD 1.53B
现金及等价物
USD 442.21M
销售成本
USD 33.51M
流动资产
USD 1.09B
流动负债
USD 187.11M
债务
USD 253.71M
EBIT
USD 34.8M
EBITDA
USD 51.69M
员工
338
EPS每股收益
USD 0.12
股本和储备
USD 583.13M
销售毛利
USD 171.41M
债务利息支出
USD 7.67M
贷款资金
USD 745.14M
市值
USD 8.97B
净收入
USD 19.78M
营业费用
USD 170.12M
营业利润
USD 34.8M
普通股股本
USD 155.31M
PE价格收益
10.76
税前利润
USD 20.36M
销售收入
USD 194.8M
销售和管理费用
USD 73.14M
股票
USD 129.03M
贸易债权人
USD 148.85M
应收帐款人
USD 392.05M


流动资产 更改 日
AbbVie USD 33.53B 4.47B 2026-03
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Ardelyx USD 381.87M 447K 2026-03
Arrowhead Research USD 1.84B 665.36M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Biogen USD 9.19B 216.3M 2026-03
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Curis USD 6.92M 7.5M 2025-12
Gilead Sciences USD 18.64B 1.25B 2026-03
J&J USD 59.17B 3.55B 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Novavax USD 850.82M 127.46M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
TG Therapeutics USD 1.09B 456.2M 2026-03
Verastem USD 223.41M 69.36M 2025-12
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03